New Zealand Blood Service, Auckland, New Zealand.
Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Blood Transfus. 2023 Sep;21(5):428-436. doi: 10.2450/2022.0178-22. Epub 2022 Dec 22.
Children have different clinical and physiological drivers for transfusion from adult recipients. However, adverse transfusion reactions (ATRs) in pediatric patients are usually reported using the same criteria as for adults. Broad assessments of pediatric ATRs neglect substantial variation in different developmental stages.
This retrospective study included 342,950 patients, ~2.43 million transfusions, and 5,540 ATR reports collated from New Zealand hospitals between 2005 and 2021. Using 16 years as the upper age limit, 138,856 pediatric transfusions and 402 pediatric ATR reports were identified and dissected at three levels: pediatric as a whole, pediatric developmental stage (i.e., neonate, infant, preschool, and school), and chronological age to identify patients at high risk of ATRs. Multivariate logistic regression analysis was followed to quantify risk factors.
Pediatric recipients had a higher ATR risk than adults (p=6.9) but the high risk was associated mainly with children older than 2 years. Neonates and infants accounted for 75.0% of pediatric recipients but had much lower ATR rates than adults. Pediatric transfusion recipients showed a clear male bias prior to age 11 years and then a female bias. However, gender difference in experiencing ATRs was significant only after age 13 years (p=2.3). Analyses focusing on the high-risk group revealed allergic reactions being the cause of the elevated risk and identified the main risk factors of number of transfusions (p=4.5) and multiple types of components transfused (p=2.0).
The identified ATR risk factors signal linkage with the biological drivers for transfusion. Low ATR rates in infancy could also be attributed to use of neonatal components, low transfusions per patient, and less developed immunity. The relative increase in female recipients from age 11 may be associated with increased red blood cell demand following puberty.
儿童与成人接受者相比,输血具有不同的临床和生理驱动因素。然而,儿科患者的不良反应(ATR)通常使用与成人相同的标准报告。对儿科 ATR 的广泛评估忽略了不同发育阶段的实质性差异。
本回顾性研究纳入了 2005 年至 2021 年间新西兰医院收集的 342950 名患者、约 243 万次输血和 5540 次 ATR 报告。使用 16 岁作为上限年龄,确定并剖析了 138856 例儿科输血和 402 例儿科 ATR 报告,分为三个层次:儿科整体、儿科发育阶段(即新生儿、婴儿、学龄前和学龄)和年龄,以确定 ATR 风险较高的患者。随后进行多变量逻辑回归分析以量化危险因素。
儿科受者的 ATR 风险高于成人(p=6.9),但高风险主要与 2 岁以上的儿童有关。新生儿和婴儿占儿科受者的 75.0%,但 ATR 发生率低于成人。儿科输血受者在 11 岁之前表现出明显的男性偏倚,然后是女性偏倚。然而,仅在 13 岁后,ATR 经历的性别差异才具有统计学意义(p=2.3)。对高危组的分析表明,过敏反应是导致风险增加的原因,并确定了输血次数(p=4.5)和输注多种类型成分(p=2.0)的主要危险因素。
确定的 ATR 危险因素与输血的生物学驱动因素有关。婴儿期 ATR 发生率低可能归因于使用新生儿成分、每位患者的输血次数少和免疫功能发育不全。11 岁后女性受者的相对增加可能与青春期后对红细胞的需求增加有关。